6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 8S114

Hubmed

  • Medea™ automates the most time-consuming phases of Clinical Evaluation Report production — helping Medical Device compliance teams and CROs meet EU MDR 2017/745 requirements faster, more accurately, and with permanent audit readiness.
About Hubmed

We are a specialized Swiss AI software house on a mission to resolve the complexities of modern R&D. As an independent leader in biotech innovation, HubMed bridges the gap between massive scientific datasets and actionable breakthroughs. We empower the world’s leading researchers to move faster, stay compliant, and protect their most valuable intellectual property with total autonomy.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 8S114
  • Country/Region:
    Italy
  • Founded:
    2026
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
Start-up
Primary activities
Technology
Contact info
  • Lugano- Switzerland, Via Lucino 28 - Breganzona - Lugano (CH), 6001, Lugano, Switzerland, Italy

Products from Hubmed (1)

  • Medea

    Product Medea

    Medea™ automates the most time-consuming phases of Clinical Evaluation Report production — helping Medical Device compliance teams and CROs meet EU MDR 2017/745 requirements faster, more accurately, and with permanent audit readiness.

    The Problem Medea™ SolvesUnder EU MDR 2017/745, every medical dev...

Hubmed Resources (2)

  • News HubMed lancia Medea™, la piattaforma AI per la valutazione clinica conforme all’EU MDR

    HubMed Technologies GmbH, azienda svizzera di software AI dedicata alla trasformazione del ciclo di vita della ricerca e sviluppo (R&D) nelle Life Sciences, ha annunciato il lancio ufficiale di Medea™, una piattaforma basata sull’intelligenza artificiale sviluppata per automatizzare, strutturare e rendere audit-ready i Rapporti di Valutazione Clinica, o Clinical Evaluation Reports (CER), richiesti dal regolamento europeo sui dispositivi medici EU MDR 2017/745.

    La soluzione, parte della piattaforma HubMed™, è disponibile da oggi sul mercato in modalità SaaS cloud-based ed è accessibile direttamente via browser, senza necessità di installazione. È pensata in particolare per Contract Research Organizations (CRO) e produttori di dispositivi medici chiamati a operare in un contesto regolatorio sempre più esigente. I primi mercati target indicati dall’azienda sono Italia, Svizzera e Unione Europea. Medea™ consente di ridurre fino al 70% i tempi dedicati alla stesura del CER
  • Video Medea™ is designed with the EUDAMED 2026/27 mandatory registration requirements in mind, ensuring that documentation workflows are aligned with the evolving European regulatory infrastructure.

    Medea™ automates the most time-consuming phases of Clinical Evaluation Report production — helping Medical Device compliance teams and CROs meet EU MDR 2017/745 requirements faster, more accurately, and with permanent audit readiness.

    Who It Is For? 
    Medical Device Compliance Teams In-house regulatory affairs and clinical evaluation teams at Medical Device manufacturers who need to produce, maintain, and update CERs across their product portfolio — without scaling headcount proportionally to the growing MDR documentation burden.

    Contract Research Organizations (CROs) CROs providing clinical evaluation and regulatory affairs services to Medical Device clients, who need to increase throughput, reduce per-CER cost, and deliver consistently high-quality, audit-ready documentation to their clients.